The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study
2008 ◽
Vol 6
(1)
◽
pp. 25-31
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 55
(3)
◽
pp. 401-408
◽
2013 ◽
Vol 333
◽
pp. e322-e323
◽